Skip to content
Search
About WifOR
Health
Burden of Disease
Health Economy Reporting
Health ROI Assessor
Social Impact
Impact Analysis
Offering
Economic and R&D Footprint
Impact Accounting
Scope 3 Assessment
WISIT – the WifOR Institute Sustainability Impact Tool
Data packages
GHG Emission Factors
Spend-based Multipliers for Sustainability Analysis
Value Factors
Ressources
Benchmarks
Value Factors
Labor Market
Big Data Skills Analysis
Diversity, Equity & Inclusion
Diversity study
Employer Attractiveness Analysis
Workforce Forecasts
Publications
Newsroom
Career
DE
EN
Contact
Latest publications
Journal publication
May Abdel-Wahab, Francesco Giammarile, Mauro Carrara, et al.
09/2024
Radiotherapy and theranostics: a Lancet Oncology Commission
Method paper
Dr. Richard Scholz, Tabea Dorndorf, Jasmin Tesch, Robert Köster, Dr. Daniel Croner, Dr. Zarko Kalamov, Jana Setzer
05/2025
Impact Measurement Using WifOR’s Sustainability Footprint Method
Study
Davide Lovera, Dr. Jasper Ubels, Dr. Malina Müller
02/2026
The Socioeconomic Burden of Migraine in Belgium
Library
Research area
Career
Health
Impact Analysis
Labor Market
Newsletter
Publication type
Conference poster
Journal publication
Method paper
Scientific article
Study
Conference poster
2025
Are European Healthcare Systems Prepared for a Potential Rapid Rise in Radioligand Therapy Eligible Patient Numbers?
Leonhard Schaetz, Margarida Goulart, Roberta Cirillo, Dr. Diego Hernandez, Dr. Platon Peristeris, Andreas Poschenreider, Panagiota Papaioannou, Panos Kanavos, Christian la Fougère, Uwe Holzwarth
Study
2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden of HER2+ Breast Cancer, Diabetic Macular Edema, Age-related Macular Degeneration and Annual Social Impact of Roche’s Treatments for Diseases in LATAM
Adnan Atitallah, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris
Study
2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden of HER2+ Breast Cancer and Annual Social Impact of Roche’s Treatments for the Disease in Africa
Adnan Atitallah, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris
Study
2025
The Value of Investing in Innovative Medicines: Socioeconomic Burden and Annual Social Impact of Roche Treatments for HER2+ Breast Cancer, Multiple Sclerosis and Retinal Disease
Adnan Atitallah, Jennifer Branner, Prof. Dr. Dennis A. Ostwald, Dr. Rebecca Grün, Dr. Maren Herrlitz, Dr. Eva Levi, Davide Lovera, Dr. Malina Müller, Dr. Platon Peristeris, Lena Steinbeck
Method paper
2025
The Health Taxonomy – The Need for a Common Investment Toolkit to Scale Up Future Investments in Health
Hatice Beton, Dr. Roberto Durán-Fernández, In collaboration with Prof. Dr. Dennis Ostwald, Prof. Rifat Atun
Study
2025
The Socioeconomic Burden of Migraine: The Case of 6 European Countries
Davide Lovera, Dr. Jasper Ubels
‹
1
2
3
4
5
6
…
21
›
Interested in our newsletter?
Register
